Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Publication
, Conference
Silverman, SL; Siris, E; Kendler, DL; Belazi, D; Brown, JP; Gold, DT; Lewiecki, EM; Papaioannou, A; Simonelli, C; Ferreira, I; Dakin, P; Ho, P ...
Published in: Osteoporosis International
September 19, 2014
Summary: To determine persistence with subcutaneous denosumab every 6 months in women being treated for osteoporosis, we conducted a single-arm prospective, observational study in the United States and Canada. Among 935 patients enrolled, 12-month persistence was 82 %, with 66 patients (7 %) reporting serious adverse events and 19 patients (2 %) reporting fractures.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Osteoporosis International
DOI
EISSN
1433-2965
ISSN
0937-941X
Publication Date
September 19, 2014
Publisher
Springer-Verlag London Ltd
Related Subject Headings
- Endocrinology & Metabolism
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 0903 Biomedical Engineering
Citation
APA
Chicago
ICMJE
MLA
NLM
Silverman, S. L., Siris, E., Kendler, D. L., Belazi, D., Brown, J. P., Gold, D. T., … Recknor, C. (2014). Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study (Accepted). In Osteoporosis International. Springer-Verlag London Ltd. https://doi.org/10.1007/s00198-014-2871-6
Silverman, S. L., E. Siris, D. L. Kendler, D. Belazi, J. P. Brown, D. T. Gold, E. M. Lewiecki, et al. “Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study (Accepted).” In Osteoporosis International. Springer-Verlag London Ltd, 2014. https://doi.org/10.1007/s00198-014-2871-6.
Silverman SL, Siris E, Kendler DL, Belazi D, Brown JP, Gold DT, et al. Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study (Accepted). In: Osteoporosis International. Springer-Verlag London Ltd; 2014.
Silverman, S. L., et al. “Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study (Accepted).” Osteoporosis International, Springer-Verlag London Ltd, 2014. Scopus, doi:10.1007/s00198-014-2871-6.
Silverman SL, Siris E, Kendler DL, Belazi D, Brown JP, Gold DT, Lewiecki EM, Papaioannou A, Simonelli C, Ferreira I, Balasubramanian A, Dakin P, Ho P, Siddhanti S, Stolshek B, Recknor C. Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study (Accepted). Osteoporosis International. Springer-Verlag London Ltd; 2014.
Published In
Osteoporosis International
DOI
EISSN
1433-2965
ISSN
0937-941X
Publication Date
September 19, 2014
Publisher
Springer-Verlag London Ltd
Related Subject Headings
- Endocrinology & Metabolism
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 0903 Biomedical Engineering